Cargando…

Future MS care: a consensus statement of the MS in the 21st Century Steering Group

The “MS in the 21st Century” initiative was established with the purpose of (1) defining how multiple sclerosis (MS) treatment and standards of care should look in the 21st century; (2) developing a minimum standard of care across the world; and (3) motivating the broad MS community to align standar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rieckmann, Peter, Boyko, Alexey, Centonze, Diego, Coles, Alasdair, Elovaara, Irina, Havrdová, Eva, Hommes, Otto, LeLorier, Jacques, Morrow, Sarah A., Oreja-Guevara, Celia, Rijke, Nick, Schippling, Sven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566385/ https://www.ncbi.nlm.nih.gov/pubmed/22936203 http://dx.doi.org/10.1007/s00415-012-6656-6

Ejemplares similares

Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS Care
por: Oreja-Guevara, Celia, et al.
Publicado: (2019)

Family Planning in Fertile-Age Patients With Multiple Sclerosis (MS) (ConPlanEM Study): Delphi Consensus Statements
por: Oreja-Guevara, Celia, et al.
Publicado: (2023)

Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy
por: Havrdova, Eva, et al.
Publicado: (2017)

Improving patient–physician dialog: commentary on the results of the MS Choices survey
por: Lugaresi, Alessandra, et al.
Publicado: (2012)

Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis
por: Schmierer, Klaus, et al.
Publicado: (2022)

Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings
por: Coles, Alasdair J., et al.
Publicado: (2017)

Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients
por: Giovannoni, Gavin, et al.
Publicado: (2016)

Pharmacologically pertinent period of effect (PPPE)
por: Suissa, Melanie, et al.
Publicado: (2019)

Analysis of Myosin Heavy Chain Isoforms from Longissimus Thoracis Muscle of Hanwoo Steer by Electrophoresis and LC-MS/MS
por: Kim, Gap-Don
Publicado: (2014)

Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study
por: Wray, Sibyl, et al.
Publicado: (2018)

Summary of Research: Collaboration Between Healthcare Professionals and People with Multiple Sclerosis to Develop Communication Tools to Improve the Standard of Multiple Sclerosis Care
por: Oreja-Guevara, Celia, et al.
Publicado: (2023)

Humoral Immune Response to SARS-CoV-2 Vaccination in MS Patients
por: Oreja-Guevara, Celia, et al.
Publicado: (2022)

Performance of the high-dimensional propensity score in adjusting for unmeasured confounders
por: Guertin, Jason R, et al.
Publicado: (2016)

A Case of Intermittent Left Bundle Branch Block
por: Saad, Syed M, et al.
Publicado: (2021)

Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets
por: Yamout, Bassem I, et al.
Publicado: (2022)

Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS
por: Arnold, Douglas L., et al.
Publicado: (2016)

Utilizing the 3Ms of Process Improvement
por: Morrow, Richard
Publicado: (2012)

Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice
por: Rieckmann, Peter, et al.
Publicado: (2021)

Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial
por: Coles, Alasdair J., et al.
Publicado: (2021)

Increased Female MS Incidence and Differences in Gender-Specific Risk in Medium- and High-Risk Regions in Finland from 1981–2010
por: Holmberg, Markus, et al.
Publicado: (2013)

Utilizing the 3Ms of Process Improvement in Healthcare
por: Morrow, Richard
Publicado: (2017)

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS
por: Ribbons, Karen Ann, et al.
Publicado: (2015)

Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study
por: Barrero, Francisco, et al.
Publicado: (2020)

Development and usability testing of your MS questionnaire: A patient-based digital tool to monitor symptoms of multiple sclerosis
por: Giovannoni, Gavin, et al.
Publicado: (2023)

Bias within economic evaluations – the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug
por: Guertin, Jason R, et al.
Publicado: (2015)

Cardiac Manifestations in a Case of Severe Hyperkalemia
por: Saad, Syed M, et al.
Publicado: (2021)

VENTRICULAR ARRHYTHMIA AND SINUS PAUSE IN THE SETTING OF COVID-19
por: Ahmed, Jameel, et al.
Publicado: (2022)

Diffusion Tensor Imaging in NAWM and NADGM in MS and CIS: Association with Candidate Biomarkers in Sera
por: Natarajan, Renuka, et al.
Publicado: (2013)

Comparison of Flow Injection-MS/MS and LC-MS/MS for the Determination of Ochratoxin A
por: Zhang, Kai
Publicado: (2021)

Multiple sclerosis in the Arabian Gulf countries: a consensus statement
por: Bohlega, Saeed, et al.
Publicado: (2013)

Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
por: Centonze, Diego, et al.
Publicado: (2021)

Head to head comparison of the propensity score and the high-dimensional propensity score matching methods
por: Guertin, Jason R., et al.
Publicado: (2016)

Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts
por: Berger, Thomas, et al.
Publicado: (2016)

Determination of Nine Fentanyl Drugs in Hair Samples by GC-MS/MS and LC-MS/MS
por: Wei, Qi, et al.
Publicado: (2022)

Determination of 355 Pesticides in Lemon and Lemon Juice by LC-MS/MS and GC-MS/MS
por: Aslantas, Sule, et al.
Publicado: (2023)

Increasing Incidence in Relapsing-Remitting MS and High Rates among Young Women in Finland: A Thirty-Year Follow-Up
por: Sumelahti, Marja-Liisa, et al.
Publicado: (2014)

Caregiver Involvement in MS: Duty or Disruption?
por: Kesselring, Jürg, et al.
Publicado: (2021)

Determination of 77 Multiclass Pesticides and Their Metabolitesin Capsicum and Tomato Using GC-MS/MS and LC-MS/MS
por: Naik Rathod, Harischandra, et al.
Publicado: (2021)

MS-DIAL: Data Independent MS/MS Deconvolution for Comprehensive Metabolome Analysis
por: Tsugawa, Hiroshi, et al.
Publicado: (2015)

Consensus statement: loneliness in older adults, the 21st century social determinant of health?
por: Prohaska, Thomas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7gf72j77s04lvfrj4jm32pq5nf